Minimal Residual Disease Negativity Is a New End Point of Myeloma Therapy
Harousseau, Jean-Luc, Avet-Loiseau, HerveVolume:
35
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2017.73.1331
Date:
September, 2017
File:
PDF, 579 KB
2017